Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Research & Development: 2011-2024

Historic Research & Development for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $1.8 million.

  • Adma Biologics' Research & Development rose 270.87% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 102.14%. This contributed to the annual value of $1.8 million for FY2024, which is 45.06% down from last year.
  • As of FY2024, Adma Biologics' Research & Development stood at $1.8 million, which was down 45.06% from $3.3 million recorded in FY2023.
  • Adma Biologics' Research & Development's 5-year high stood at $5.9 million during FY2020, with a 5-year trough of $1.8 million in FY2024.
  • For the 3-year period, Adma Biologics' Research & Development averaged around $2.9 million, with its median value being $3.3 million (2023).
  • Data for Adma Biologics' Research & Development shows a maximum YoY crashed of 45.06% (in 2024) over the last 5 years.
  • Adma Biologics' Research & Development (Yearly) stood at $5.9 million in 2020, then crashed by 38.28% to $3.6 million in 2021, then dropped by 0.88% to $3.6 million in 2022, then decreased by 8.69% to $3.3 million in 2023, then tumbled by 45.06% to $1.8 million in 2024.